2m 2m 2m 2m 2m 2m 2m
CAMP4 THERAP (CAMP)
NASDAQ
$4.19+$0.01 (+0.36%)
Price as of Jun 03, 2026 4:10 PM EDT- $228.0MMarket Cap
- 105.15%1-Year Change
- BiotechnologyIndustry
CAMP4 THERAP (CAMP)
$4.19+$0.01 (+0.36%)
CAMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.17 | ||
Change | -$0.06 (-1.49%) | ||
Open | $3.98 | ||
High | $4.22 | ||
Low | $3.93 | ||
Previous Close | $3.98 | ||
Volume | 48,446 | ||
30-Day Average Volume | 79,482 | ||
1-Week Change | -2.93% | ||
1-Month Change | -1.73% | ||
1-Year Change | 105.15% | ||
3-Year Change | -90.39% | ||
5-Year Change | -98.75% | ||
Fundamentals | |||
Shares Outstanding | 51.9M | ||
Total Assets | $105.5M | ||
Market Cap | $228.0M | ||
Enterprise Value | $128.7M | ||
Period: QTR TTM FY | |||
Revenue | $1.3M | ||
Net Income | -$18.3M | ||
Free Cash Flow | -$11.0M | ||
EBIT | -$18.3M | ||
EBITDA | -$17.8M | ||
Net Working Capital | $85.6M | ||
EPS | -$0.32 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 99 | ||
P/B | 7 | ||
P/E | -14 | ||
PEG | -0 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 23 | ||
Last Split Date | 02/02/2024 | ||
Earnings & Revenue